SILK PROTEINS FOR MORE STABLE VACCINES

The video discusses the problem of vaccine instability due to the need for refrigeration, which poses challenges in shipping and storage, especially in developing countries. Vaxes has developed a silk-derived protein stabilizer that improves vaccine stability, allowing vaccines to be shipped without refrigeration. This innovation could eliminate the need for cold storage, making vaccine distribution more efficient and cost-effective.

What challenges do developing countries face in vaccine storage?

What is the significance of eliminating the need for cold storage in vaccine distribution?